|
EW | Edwards Lifesciences Corp |
|
|
EW | Edwards Lifesciences Corp |
| Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Book value per $ invested | $ 0.66 |
| Leverage | 22.53% |
| Market Cap | $ 45.8B |
| PE | 11.05 |
| Dividend Yield | 0.00% |
| Profit | $ 4.1B |
| Margin | 74.19% |
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.